openPR Logo
Press release

Online Case Evaluations Available for Women Injured by Vaginal Mesh

12-26-2011 06:39 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Women who have suffered serious complications after receiving a transvaginal mesh implant may now find free legal help online.

Los Angeles, CA, December 23, 2011 – In response to the growing number of lawsuits being filed against manufacturers of vaginal mesh devices, a prominent national law firm is now offering free online help to women who are concerned about potential side effects.

Vaginal mesh was first approved the U.S. Food and Drug Administration to treat a condition known as pelvic organ prolapse or POP. The condition is a weakening of the pelvic floor muscles typically caused by childbirth, hysterectomy or weight gain. Women who develop POP may experience incontinence or other adverse side effects.

Since 2008, the FDA has received several thousand complaints from women across the country who claim they were seriously injured by a transvaginal mesh implant. Complications allegedly caused by these devices including severe abdominal pain, internal scarring, blood vessel and tissue damage, infection and pain during intercourse.

In July 2011, the FDA issued an updated safety communication advising women of the potential risks associated with vaginal mesh devices. Since the warning was issued a flood of lawsuits have been filed Johnson & Johnson, C.R. Bard, American Medical Systems and Boston Scientific by women who claim they the devices manufactured by these companies were defective.

A number of these cases have been consolidated in to multidistrict litigations in federal courts across the country. The first bellweather trials in the vaginal mesh litigation are scheduled to begin in November 2012 in a New Jersey Superior Court. These cases involved approximately 600 claims filed against Johnson & Johnson which allege injuries caused by the company’s Ethicon Gynecare mesh system.

While the FDA currently has no plans to issue a recall of any vaginal mesh devices, concerns over the safety of these products prompted the American College of Obstetricians and Gynecologists and the American Urogynecologic Society (AUGS) to issue a joint opinion in November 2011 recommending limiting the use of the implants only to those high-risk women for whom the benefits would outweigh the risks. In addition to these recommendations, members of the U.S. Senate are seeking to require vaginal mesh manufacturers to implement enhanced safety tracking techniques for these devices once they become available to the public.

Prominent national law firm Nadrich & Cohen LLP has created a new online resource center for women in all 50 states who are seeking information about the vaginal mesh litigation. In addition, visitors to www.VaginalMeshLegalClaims.com may also complete a confidential online contact form to schedule a free initial case evaluation. Help is also available by calling the firm’s injury hotline at 1-800-722-0765.

Nadrich & Cohen LLP is a national law firm specializing in representing clients nationwide who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, traffic accidents, workplace accidents and dog bites. To learn more about our firm, visit www.PersonalInjuryLawCal.com.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Online Case Evaluations Available for Women Injured by Vaginal Mesh here

News-ID: 205334 • Views:

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for Johnson

Urgent Care Apps Market 2019 Analysis by Johnson & Johnson (Johnson & Johnson He …
"the Global Urgent Care Apps market is accounted for $312.93 million in 2017 and is expected to reach $6,382.75 million by 2026 growing at a CAGR of 39.8%. Growing demand owing to growing focus on patient-centric healthcare delivery and increase in penetration of 3G and 4G networks are some key factors influencing the market growth. However, poor internet connectivity in developing countries is restricting the growth of the market. In
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumers
Wet Tissues Market 2017- Johnson & Johnson, SC Johnson, Clorox, Beiersdorf, 3M
Apex Research, recently published a detailed market research study focused on the "Wet Tissues Market" across the global, regional and country level. The report provides 360° analysis of "Wet Tissues Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wet Tissues industry, and estimates the future trend of Wet Tissues market on
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360° analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of this
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso …
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Sales